Journal of Translational Medicine

Table 1 Clinical characteristics of patients suffering from CP and healthy controls

From: St13 protects against disordered acinar cell arachidonic acid pathway in chronic pancreatitis

Variable	Univariate analysis
Variable	Normal (n = 143)	ACP (n = 91)	NACP (n = 277)	P₀-value	P₁-value	P₂-value
Age (years)	48.81±9.05	49.29 ± 13.22	51.63 ± 14.56	0.061	0.076	0.071
Sex (M/F)	83/60	279/122	95/112	0.052	0.064	0.062
BMI	24.5 ± 2.97	28.12 ± 4.14	27.11 ± 3.83	0.002^a	0.000^a	0.140
Smoking (Y/N)	45/68	139/262	44/163	0.035^a	0.001^a	0.041^a
Weight loss (Y/N)	8/135	92/309	78/123	0.094	0.104	0.297
Laboratory examination
Amylase (U/l)	113.45 ± 60.40	261.17 ± 311.15	244.18 ± 472.10	0.092	0.487	0.443
Lipase (U/l)	35.40 ± 13.80	428.19 ± 1044.22	252.54 ± 320.19	0.003^a	0.093	0.115
TG (mmol/l)	0.81 ±0.47	1.20 ±2.00	0.71 ±1.32	0.035^a	0.042^a	0.031^a
CHOL (mmol/l)	2.47 ±1.50	4.29 ±1.39	2.33 ±2.10	0.007^a	0.003^a	0.027^a
HDL (mmol/l)	1.56 ±2.58	0.98 ±0.43	0.77 ±0.36	0.188	0.171	0.484
LDL (mmol/l)	1.52 ±0.90	2.57 ±0.92	1.29 ±1.87	0.000^a	0.002^a	0.045^a
VLDL (mmol/l)	0.82 ±0.33	0.54 ±0.98	0.67 ±1.63	0.753	0.826	0.076

P0: Normal vs ACP
P1: Normal vs NACP
P2: ACP vs NACP
^aStatistically significant results (p < 0.05).

Back to article page

ISSN: 1479-5876

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com